Registry of Chronic Subdural Hematoma
Launched by ERASMUS MEDICAL CENTER · Dec 29, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Registry of Chronic Subdural Hematoma (CSDH), is studying how this condition develops and how patients are treated. CSDH is a collection of blood on the brain that can happen after a head injury or without any obvious cause. The researchers want to learn more about what patients are like when they are first diagnosed, what treatments they get, and how they feel and function after treatment—specifically looking at their ability to think and move.
To participate in this study, you need to be at least 18 years old and have been diagnosed with CSDH. If you join, you'll continue with your standard treatment and will be asked to take a quick phone interview three months later to discuss your recovery. This study aims to help improve understanding and care for people with CSDH, so your experience and information could really make a difference!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients diagnosed with CSDH
- • 18 years or older
- Exclusion Criteria:
- • Patients who do not consent to participate in the registry
About Erasmus Medical Center
Erasmus Medical Center, located in Rotterdam, Netherlands, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent institution within the Erasmus University Rotterdam, the center integrates cutting-edge scientific inquiry with comprehensive patient care, focusing on a wide range of medical specialties. With a strong emphasis on multidisciplinary collaboration, Erasmus Medical Center aims to translate research findings into tangible clinical applications, enhancing treatment options and improving patient outcomes. The institution is dedicated to conducting ethical and rigorous clinical trials that contribute to the global body of medical knowledge and foster advancements in personalized medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rotterdam, , Netherlands
Amsterdam, , Netherlands
Patients applied
Trial Officials
Ruben Dammers
Principal Investigator
Erasmus Medical Center
Dagmar Verbaan
Principal Investigator
Amsterdam UMC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported